199 related articles for article (PubMed ID: 3012546)
1. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
[TBL] [Abstract][Full Text] [Related]
2. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and serological characterization of an altered c-abl gene product produced in Ph1 CML patients.
Mes-Masson AM; McLaughlin J; Witte O
Haematol Blood Transfus; 1987; 31():163-6. PubMed ID: 3127280
[TBL] [Abstract][Full Text] [Related]
4. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.
Mes-Masson AM; McLaughlin J; Daley GQ; Paskind M; Witte ON
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9768-72. PubMed ID: 3540951
[TBL] [Abstract][Full Text] [Related]
5. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
6. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
[TBL] [Abstract][Full Text] [Related]
7. Expression of the hybrid P210 bcr/abl protein in Philadelphia chromosome positive B-lymphoid cell lines.
Stacchini A; Ponzetto C; Guerrasio A; Martinotti G; Rege Cambrin G; Scaravaglio P; Rosso C; Piacibello W; Aglietta M; Saglio G
Haematologica; 1989; 74(3):249-54. PubMed ID: 2511093
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
[TBL] [Abstract][Full Text] [Related]
9. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.
Hermans A; Heisterkamp N; von Linden M; van Baal S; Meijer D; van der Plas D; Wiedemann LM; Groffen J; Bootsma D; Grosveld G
Cell; 1987 Oct; 51(1):33-40. PubMed ID: 2820585
[TBL] [Abstract][Full Text] [Related]
10. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
11. Absence of the hybrid bcr-abl mRNA in Ph1-positive B lymphoblastoid cell lines established from a patient with chronic myelogenous leukemia.
Yamada T; Oikawa T; Kuzumaki N; Takagi N; Sasaki M
Int J Cancer; 1987 Dec; 40(6):778-83. PubMed ID: 3121521
[TBL] [Abstract][Full Text] [Related]
12. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
[TBL] [Abstract][Full Text] [Related]
13. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
14. Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.
Croce CM; Huebner K; Isobe M; Fainstain E; Lifshitz B; Shtivelman E; Canaani E
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7174-8. PubMed ID: 3118359
[TBL] [Abstract][Full Text] [Related]
15. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of chronic myelogenous leukemia.
Dreazen O; Canaani E; Gale RP
Semin Hematol; 1988 Jan; 25(1):35-48. PubMed ID: 3279514
[TBL] [Abstract][Full Text] [Related]
17. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
Clark SS; McLaughlin J; Timmons M; Pendergast AM; Ben-Neriah Y; Dow LW; Crist W; Rovera G; Smith SD; Witte ON
Science; 1988 Feb; 239(4841 Pt 1):775-7. PubMed ID: 3422516
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.
Shtivelman E; Lifshitz B; Gale RP; Roe BA; Canaani E
Cell; 1986 Oct; 47(2):277-84. PubMed ID: 3021337
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
[TBL] [Abstract][Full Text] [Related]
20. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
McLaughlin J; Chianese E; Witte ON
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6558-62. PubMed ID: 3498165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
